Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Bayer AG | 926 |
| 2 | Roche Holding AG | 884 |
| 3 | Novartis AG | 649 |
| 4 | Fujifilm Holdings Corp | 578 |
| 5 | BASF SE | 521 |
| 6 | Pfizer Inc | 499 |
| 7 | Johnson and Johnson | 383 |
| 8 | Merck and Co Inc | 329 |
| 9 | Daiichi Sankyo Co Ltd | 312 |
| 10 | Sanofi SA | 280 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C07D | Heterocyclic compounds | 15,461 |
| 2 | A61P | Therapeutic activity (drug indications) | 13,136 |
| 3 | A61K | Medicinal preparations | 8,358 |
| 4 | C07C | Acyclic and carbocyclic compounds | 5,910 |
| 5 | C07K | Peptides | 2,314 |
| 6 | C07F | Organometallic compounds | 1,728 |
| 7 | A01N | Preservation of bodies; biocides; pest repellents | 1,554 |
| 8 | Y02P | Climate change mitigation: production | 1,385 |
| 9 | G03F | 1,333 | |
| 10 | C07B | General methods of organic chemistry | 1,095 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Method for preparing chloramphenicol from 4-chlorobenzaldehyde | 2012 | 4 | |
| Method for synthesizing chloramphenicol from 4-chlorobenzaldehyde | 2012 | 2 | |
| Preparation method and application of 3-methoxy-4-chlorobenzaldehyde | 2025 | 0 | |
| The synthetic method of fenarol pharmaceutical intermediate 4- chlorobenzaldehydes | 2018 | 0 | |
| Fenner dew drug intermediates 4-chlorobenzaldehyde synthesis method | 2018 | 0 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Hoong‐Kun Fun | Universiti Sains Malaysia | 14 |
| 2 | Muhammad Nawaz Tahir | University of Sargodha | 6 |
| 3 | Edward R. T. Tiekink | University of Malaya | 4 |
| 4 | Noriyuki Yonezawa | Tokyo University of Agriculture and Technology | 4 |
| 5 | Akiko Okamoto | Tokyo University of Agriculture and Technology | 4 |
| 6 | Bohari M. Yamin | National University of Malaysia | 4 |
| 7 | Ray J. Butcher | Howard University | 4 |
| 8 | Seik Weng Ng | University of Malaya | 4 |
| 9 | Keiichi Noguchi | Tokyo University of Agriculture and Technology | 3 |
| 10 | H. Stoeckli‐Evans | University of Neuchâtel | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Switchable Perfomance of an l -Proline-Derived Basic Catalyst Controlled by Supramolecular Gelation | 2009 | 181 | Supramolecular Chemistry and Complexes |
| Organosilanols as Catalysts in Asymmetric Aryl Transfer Reactions | 2005 | 102 | Asymmetric Synthesis and Catalysis |
| An efficient, multicomponent approach for solvent-free synthesis of 2-amino-4H-chromene scaffold | 2010 | 91 | Synthesis and biological activity |
| Indolyl esters and amides related to indomethacin are selective COX-2 inhibitors | 2005 | 84 | Synthesis and biological activity |
| Metabolism of 4,4′-dichlorobiphenyl by white-rot fungi Phanerochaete chrysosporium and Phanerochaete sp. MZ142 | 2006 | 72 | Microbial bioremediation and biosurfactants |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of 4-chlorobenzaldehyde?
Which organizations hold the most patents involving 4-chlorobenzaldehyde?
How many patents and papers involving 4-chlorobenzaldehyde have been published in recent years?
What are common applications of 4-chlorobenzaldehyde based on patent classification?
What specific pharmaceutical applications have been patented for 4-chlorobenzaldehyde?